Buell Jennifer is Chief Executive Officer of MiNK Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Protagenic Therapeutics, Inc.\new
29 Mar 24
4
MiNK Therapeutics, Inc.
18 Jan 24
4
MiNK Therapeutics, Inc.
13 Oct 23
4
MiNK Therapeutics, Inc.
3 Oct 23
4
MiNK Therapeutics, Inc.
29 Sep 23
4
MiNK Therapeutics, Inc.
11 Jan 23
4
MiNK Therapeutics, Inc.
25 Jan 22
3
MiNK Therapeutics, Inc.
20 Oct 21
4
AGENUS INC
2 Jul 21
4
AGENUS INC
5 Apr 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | PTIX Protagenic Therapeutics | PTIX Common stock Options PTIX Common Stock, Par Value $0.0001 | Grant | Acquire A | No | No | 1.74 | 75,000 | 130.50 k | 75,000 |
16 Jan 24 | INKT MiNK Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.87 | 660,919 | 575.00 k | 660,919 |
16 Jan 24 | INKT MiNK Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.87 | 500,000 | 435.00 k | 500,000 |
11 Oct 23 | INKT MiNK Therapeutics | Common Stock | Other | Dispose J | No | No | 0 | 695,750 | 0.00 | 232,165 |
11 Oct 23 | INKT MiNK Therapeutics | RSU Common Stock | Grant | Dispose A | No | No | 0 | 695,750 | 0.00 | 0 |
3 Oct 23 | INKT MiNK Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.9449 | 65,000 | 61.42 k | 927,915 |
2 Oct 23 | INKT MiNK Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 1.0445 | 58,550 | 61.16 k | 992,915 |
29 Sep 23 | INKT MiNK Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 1.1538 | 25,000 | 28.85 k | 1,051,465 |
27 Sep 23 | INKT MiNK Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 695,750 | 0.00 | 1,076,465 |
27 Sep 23 | INKT MiNK Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 695,750 | 0.00 | 695,750 |